Prostaglandin E2 regulates B cell proliferation through a candidate tumor suppressor, Ptger4.
about
E-type prostanoid receptor 4 (EP4) in disease and therapyRegulation of B lymphocytes and plasma cells by innate immune mechanisms and stromal cells in rheumatoid arthritis.Lymphoma: immune evasion strategiesGene expression profiling suggests a pathological role of human bone marrow-derived mesenchymal stem cells in aging-related skeletal diseasesProstaglandin E2 synthesizing enzymes in rheumatoid arthritis B cells and the effects of B cell depleting therapy on enzyme expressionUnveiling MYCN regulatory networks in neuroblastoma via integrative analysis of heterogeneous genomics data.Myeloid-derived suppressor cells regulate T cell and B cell responses during autoimmune diseaseProstaglandin E2 promotes proliferation of skeletal muscle myoblasts via EP4 receptor activation.Limited effect of anti-rheumatic treatment on 15-prostaglandin dehydrogenase in rheumatoid arthritis synovial tissue.Progress in multiple sclerosis genetics.MicroRNA-424 inhibits Akt3/E2F3 axis and tumor growth in hepatocellular carcinoma.Myeloid-derived suppressor cells as a potential therapy for experimental autoimmune myasthenia gravisAn inflammatory mediator, prostaglandin E2, in colorectal cancer.Protease-activated receptors and prostaglandins in inflammatory lung disease.MicroRNA-140-5p suppresses tumor growth and metastasis by targeting transforming growth factor β receptor 1 and fibroblast growth factor 9 in hepatocellular carcinoma.EP4 receptor signalling in immature B cells involves cAMP and NF-κB dependent pathways.Macrophage regulation of B cell proliferation.Colorectal adenoma to carcinoma progression is accompanied by changes in gene expression associated with ageing, chromosomal instability, and fatty acid metabolism.Eicosanoid modulation by the short-chain fatty acid n-butyrate in human monocytes.Transcriptomics analysis reveals new insights in E171-induced molecular alterations in a mouse model of colon cancer.Eicosanoid Control Over Antigen Presenting Cells in Asthma
P2860
Q26851156-175A13A5-0AFC-46C1-B9A6-445331DF3170Q27686770-E12D9893-1A78-4699-B31B-A6BC1D8F2118Q28080705-805E4108-ED05-4990-962C-8FA9E7CF0B94Q28567479-5835940F-B442-4CB7-B94D-E7D75B762270Q28743224-6ECDB510-CF1E-4E58-A9F0-793678982CB2Q31095310-12A621EF-B357-40AF-8422-E370546328F1Q35115477-F93954B8-1514-4382-A90E-D86644A3E050Q36189498-84C1BD04-902F-4A15-842D-A23479AD2A5DQ36246027-D18A29F5-3B64-42FA-8A3B-C07C361CA9CDQ36382352-AFE36141-10E5-4FE1-9873-1B17AA142431Q36413892-EEF3CBAC-A8CA-4348-AC00-12F287D3711FQ36669016-552C68E6-C839-48BC-B69D-C3C003611F17Q36701908-686B6A21-65C1-4AC0-9FE8-023572160D72Q37447476-66A51717-E35B-40CA-8D8C-BAA071B79C83Q39196206-6F44E629-7610-4CF8-B08F-4267B235BFEEQ39317792-F9E26361-616F-4686-89A0-DB0016707026Q51122070-44994ED4-8233-4BC6-B9CA-A9BC8E3E5293Q52620979-88D65CA5-AB48-4D41-A6D0-494C52086BD8Q54272518-C4632113-2EA5-4432-8B3E-8C322364DD94Q55430424-D5F1A310-6C6A-4570-9269-FA6373DB467EQ58764843-38EF312E-5DB1-4357-8B9B-CDA4C2AB0B58
P2860
Prostaglandin E2 regulates B cell proliferation through a candidate tumor suppressor, Ptger4.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 15 December 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Prostaglandin E2 regulates B c ...... date tumor suppressor, Ptger4.
@en
Prostaglandin E2 regulates B c ...... date tumor suppressor, Ptger4.
@nl
type
label
Prostaglandin E2 regulates B c ...... date tumor suppressor, Ptger4.
@en
Prostaglandin E2 regulates B c ...... date tumor suppressor, Ptger4.
@nl
prefLabel
Prostaglandin E2 regulates B c ...... date tumor suppressor, Ptger4.
@en
Prostaglandin E2 regulates B c ...... date tumor suppressor, Ptger4.
@nl
P2093
P2860
P356
P1476
Prostaglandin E2 regulates B c ...... date tumor suppressor, Ptger4.
@en
P2093
Jernej Murn
Olivier Alibert
Simon Tendil
Xavier Gidrol
P2860
P304
P356
10.1084/JEM.20081163
P407
P577
2008-12-15T00:00:00Z